$77.00 0.4%
TECH Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Bio-Techne

Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide.


Bio-Techne
Price $77.00
Target Price Sign up
Volume 20,830
Market Cap $12.2B
Year Range $56.74 - $84.15
Dividend Yield 0.41%
PE Ratio 61.85
Revenue per Employee $379,117
Industry Biotechnology

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '24299M212M205M49M85M0.480
Q4 '23268M223M177M27M58M0.400
Q3 '23272M217M185M51M75M0.410
Q2 '23298M196M205M75M111M0.550
Q1 '23293M191M202M70M101M0.530

Insider Transactions View All

HIGGINS JOHN L filed to sell 36,608 shares at $83.8.
May 16 '24
Nusse Roeland filed to sell 43,097 shares at $77.
March 11 '24
Nusse Roeland filed to sell 51,872 shares at $80.3.
September 1 '23
Kummeth Charles R. filed to sell 1,258,766 shares at $88.4.
July 25 '23
Kummeth Charles R. filed to sell 1,112,817 shares at $83.
June 9 '23

Congress Trading View All

Politician Filing Date Type Size
Rohit Khanna
Democrat
Jun 5, 24 Buy $1K - $15K
Rohit Khanna
Democrat
May 6, 24 Sell $1K - $15K
Rohit Khanna
Democrat
Nov 8, 23 Buy $1K - $15K

What is the Market Cap of Bio-Techne?

The Market Cap of Bio-Techne is $12.2B.

What is Bio-Techne's PE Ratio?

As of today, Bio-Techne's PE (Price to Earnings) ratio is 61.85.

How Many People Work at Bio-Techne?

As of our latest update, Bio-Techne employed approximately 3,000 people worldwide. However, it's important to note that Bio-Techne's workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Bio-Techne's revenue per employee?

$379,117. To calculate Bio-Techne's revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Bio-Techne?

Currently, the price of one share of Bio-Techne stock is $77.00.

How can I analyze the TECH stock price chart for investment decisions?

The TECH stock price chart above provides a comprehensive visual representation of Bio-Techne's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Bio-Techne shares. Our platform offers an up-to-date TECH stock price chart, along with technical data analysis and alternative data insights.

Does TECH offer dividends to its shareholders?

Yes, Bio-Techne (TECH) offers dividends to its shareholders, with a dividend yield of 0.41%. This dividend yield represents Bio-Techne's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Bio-Techne in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Bio-Techne?

Some of the similar stocks of Bio-Techne are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.